RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
180 Life Sciences Stock

180 Life Sciences Liabilities 2024

180 Life Sciences Liabilities

5.39 M USD

Ticker

ATNF

ISIN

US68236V1044

WKN

A2QJX5

In 2024, 180 Life Sciences's total liabilities amounted to 5.39 M USD, a -35.14% difference from the 8.31 M USD total liabilities in the previous year.

180 Life Sciences Aktienanalyse

What does 180 Life Sciences do?

180 Life Sciences Corp is a US biotechnology company that focuses on the development of treatments for chronic inflammatory diseases. The company was founded in 2018 and is headquartered in New York City. 180 Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing 180 Life Sciences's Liabilities

180 Life Sciences's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating 180 Life Sciences's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing 180 Life Sciences's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

180 Life Sciences's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in 180 Life Sciences’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about 180 Life Sciences stock

What is the level of liabilities of 180 Life Sciences this year?

180 Life Sciences has a debt balance of 5.39 M USD this year.

What were the liabilities of 180 Life Sciences compared to the previous year?

The liabilities of 180 Life Sciences have increased by -35.14% dropped compared to the previous year.

What are the consequences of high debt for investors of 180 Life Sciences?

High liabilities can pose a risk for investors of 180 Life Sciences, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in 180 Life Sciences?

Low liabilities mean that 180 Life Sciences has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of 180 Life Sciences affect the company?

An increase in liabilities of 180 Life Sciences can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of 180 Life Sciences affect the company?

A decrease in the liabilities of 180 Life Sciences can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of 180 Life Sciences?

Some factors that can influence the liabilities of 180 Life Sciences include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of 180 Life Sciences so important for investors?

The liabilities of 180 Life Sciences are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can 180 Life Sciences take to modify the liabilities?

To change its liabilities, 180 Life Sciences can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does 180 Life Sciences pay?

Over the past 12 months, 180 Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 180 Life Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of 180 Life Sciences?

The current dividend yield of 180 Life Sciences is .

When does 180 Life Sciences pay dividends?

180 Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of 180 Life Sciences?

180 Life Sciences paid dividends every year for the past 0 years.

What is the dividend of 180 Life Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is 180 Life Sciences located?

180 Life Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von 180 Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 180 Life Sciences from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.

When did 180 Life Sciences pay the last dividend?

The last dividend was paid out on 11/9/2024.

What was the dividend of 180 Life Sciences in the year 2023?

In the year 2023, 180 Life Sciences distributed 0 USD as dividends.

In which currency does 180 Life Sciences pay out the dividend?

The dividends of 180 Life Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von 180 Life Sciences

Our stock analysis for 180 Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 180 Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.